Skip to search formSkip to main contentSkip to account menu

technetium Tc 99m depreotide

Known as: Tc-99m depreotide, Technetium Tc-99m Depreotide, technetium (99mTc) depreotide 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2013
2013
A large number of chemically well defined and synthetic linear as well as branched therapeutics peptides have been developed and… 
2005
2005
BackgroundThe immunosuppressive treatment of Graves' orbitopathy (GO) influences the course of the disease in the early, active… 
2005
2005
PurposeThe aim of this study was to evaluate the clinical usefulness of scintigraphy with 99mTc-depreotide in the assessment of… 
2004
2004
AbstractInvestigating three somatostatin receptor (SSTR)-positive (+) human breast cancer cell lines, Xu et al. found a time- and… 
2004
2004
Indeterminate lung nodules (LN) constitute a clinical problem of increasing frequency that requires an effective diagnostic… 
Review
2004
Review
2004
Background99mTc-depreotide (NeoTect) is a synthetic somatostatin analogue, which binds to somatostatin receptor (SSTR) subtypes 2… 
2004
2004
PurposeScintigraphy with 99mTc-depreotide, a somatostatin analogue–technetium ligand, has been used for evaluation of various… 
2004
2004
We read the short communication by Kainz et al. [1] with great interest. We are aware of the pioneering work of the research… 
2003
2003
Somatostatin receptor scintigraphy (SRS) is useful in diagnosing tumours with increased expression of somatostatin receptors… 
Review
2001
Review
2001
The high level expression of somatostatin receptors (SSTR) on various tumor cells has provided the molecular basis for successful…